Seastar Medical Holding Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated November 21, 2023, serves as a current report for SeaStar Medical Holding Corporation (Nasdaq: ICU). The filing references a press release issued on November 14, 2023, detailing the company's financial condition and results of operations for the fiscal quarter ended September 30, 2023.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
No specific material changes versus the prior comparable period are detailed in the text of this 8-K. The document acts as a conduit to the November 14, 2023, press release for operational and financial updates.
Guidance, Outlook, and Risks
The filing does not contain specific guidance, outlook, management commentary, or risk factors within its body text. It explicitly states that the information in the referenced press release is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act, meaning it is not subject to the liabilities of that section and shall not be deemed incorporated by reference into other filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 14, 2023) for actual Q3 2023 financial figures.
- Verify the company's status as an emerging growth company (indicated as yes in the filing).
- Confirm the trading symbols: Common Stock (ICU) and Warrants (ICUCW) on The Nasdaq Stock Market LLC.
- Note that the financial data in the press release is not incorporated by reference into this 8-K.